Osteosclerosis in two brothers with autosomal dominant pseudohypoparathyroidism type 1b: Bone histomorphometric analysis

European Journal of Endocrinology

Volumn 164, Issue 2, 2011, Pages 295-301

  Sbrocchi, Anne Marie ^a   Rauch, Frank ^b   Lawson, Margaret L ^a   Hadjiyannakis, Stasia ^a   Lawrence, Sarah ^a   Bastepe, Murat ^c   Jüppner, Harald ^c   Ward, Leanne Marie ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; SYNTAXIN 16; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM ION; PHOSPHATE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BIOCHEMISTRY; BONE DENSITOMETRY; BONE RADIOGRAPHY; CASE REPORT; CHILD; CLINICAL ARTICLE; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOSCLEROSIS; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; SCHOOL CHILD; ADULT; BONE BIOPSY; BONE DENSITY; BONE LEVEL; BONE NECROSIS; CORTICAL BONE; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; ENAMEL HYPOPLASIA; GENETIC HETEROGENEITY; GENETIC SCREENING; GENOTYPE; ONSET AGE; OSTEOMETRY; PEDIGREE ANALYSIS; PSEUDOHYPOPARATHYROIDISM TYPE 1B; THICKNESS;

ADOLESCENT; BONE AND BONES; BONE DENSITY; HUMANS; MALE; OSTEOSCLEROSIS; PSEUDOHYPOPARATHYROIDISM; YOUNG ADULT;

EID: 78751515788     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0795     Document Type: Article

References (30)

1. Bastepe M. The GNAS locus and pseudohypoparathyroidism. Advances in Experimental Medicine and Biology 2008 626 27-40. (doi:10.1007/978-0-387-77576- 0-3)
2. Linglart A, Bastepe M & Jüppner H. Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clinical Endocrinology 2007 67 822-831. (doi:10.1111/j.1365-2265. 2007.02969.x) (Pubitemid 350135123)
3. Kidd GS, Schaaf M, Adler RA, Lassman MN & Wray HL. Skeletal responsiveness in pseudohypoparathyroidism. A spectrum of clinical disease. American Journal of Medicine 1980 68 772-781. (doi:10.1016/0002-9343(80)90270-3) (Pubitemid 10096045)
4. Murray TM, Rao LG, Wong MM, Waddell JP, McBroom R, Tam CS, Rosen F & Levine MA. Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone. Journal of Bone and Mineral Research 1993 8 83-91. (doi:10.1002/jbmr.5650080111)
5. Burnstein MI, Kottamasu SR, Pettifor JM, Sochett E, Ellis BI & Frame B. Metabolic bone disease in pseudohypoparathyroidism: radiologic features. Radiology 1985 155 351-356.
6. Jacobson HG. Dense bone - too much bone: radiological considerations and differential diagnosis. Part I. Skeletal Radiology 1985 13 1-20. (doi:10.1007/BF00349088)
7. Balkissoon AR & Hayes CW. Case 14: intramedullary osteosclerosis. Radiology 1999 212 708-710.
8. Long D, Levine M & Germain-Lee E. Bone mineral density in pseudohypoparathyroidism type 1a. Journal of Clinical Endocrinology and Metabolism 2010 95 4465-4475. (doi:10.1210/jc.2010-0498)
9. Juppner H, Schipani E, Bastepe M, Cole DE, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T, Crawford JD, Olsen BR & Vikkula M. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. PNAS 1998 95 11798-11803. (doi:10.1073/pnas.95.20.11798)
10. Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1997.
11. Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood 1970 45 13-23. (doi:10.1136/adc.45.239.13)
12. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF & Johnson CL. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002 109 45-60. (doi:10.1542/peds.109.1.45)
13. Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M & Parfitt AM. Normative data for iliac bone histomorphometry in growing children. Bone 2000 26 103-109. (doi:10.1016/S8756-3282(99)00257-4) (Pubitemid 30029201)
14. Rauch F, Travers R & Glorieux FH. Intracortical remodeling during human bone development - a histomorphometric study. Bone 2007 40 274-280. (doi:10.1016/j.bone.2006.09.012)
15. Bastepe M, Fröhlich LF, Hendy GN, Indridason OS, Josse RG, Koshiyama H, Korkko J, Nakamoto JM, Rosenbloom AL, Slyper AH, Sugimoto T, Tsatsoulis A, Crawford JD & Jüppner H. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. Journal of Clinical Investigation 2003 112 1255-1263. (doi:10.1172/JCI200319159)
16. Mantovani G, de Sanctis L, Barbieri AM, Elli FM, Bollati V, Vaira V, Labarile P, Bondioni S, Peverelli E, Lania AG, Beck-Peccoz P & Spada A. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. Journal of Clinical Endocrinology and Metabolism 2010 95 651-658. (doi:10.1210/jc.2009-0176)
17. Parfitt AM. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Current Opinion in Nephrology and Hypertension 2003 12 387-403. (doi:10.1097/00041552-200307000-00007)
18. Rauch F. Watching bone cells at work: what we can see from bone biopsies. Pediatric Nephrology 2006 21 457-462. (doi:10.1007/s00467-006-0025-6)
19. Duquesnoy B, Wemeau JL, Hardouin P, Delfosse JM, Grimbert I, Truquet B, Hubaud P, Decoulx M & Delcambre B. Histomorphometric data in 5 cases of pseudohypoparathyroidism: discussion on bone sensitivity to parathyroid hormone. Revue du Rhumatisme et des Maladies Ostéo-Articulaires 1986 53 243-248.
20. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK & Eriksen EF. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. Journal of Bone and Mineral Research 2003 18 1932-1941. (doi:10.1359/jbmr.2003.18.11.1932)
21. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J & Lindsay R. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. Journal of Bone and Mineral Research 2001 16 1846-1853. (doi:10.1359/jbmr.2001.16.10.1846)
22. Tollin SR, Perlmutter S & Aloia JF. Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib. Journal of Bone and Mineral Research 2000 15 1412-1416. (doi:10.1359/jbmr.2000.15.7.1412)
23. Laspa E, Bastepe M, Juppner H & Tsatsoulis A. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance. Journal of Clinical Endocrinology and Metabolism 2004 89 5942-5947. (doi:10.1210/jc.2004-0249) (Pubitemid 39628397)
24. Parfitt AM. Parathyroid hormone and periosteal bone expansion. Journal of Bone and Mineral Research 2002 17 1741-1743. (doi:10.1359/jbmr.2002.17.10.1741)
25. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O & Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New England Journal of Medicine 2001 344 1434-1441. (doi:10.1056/NEJM200105103441904)
26. Jilka RL, O'Brien CA, Ali AA, Roberson PK, Weinstein RS & Manolagas SC. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone 2009 44 275-286. (doi:10.1016/j.bone.2008.10. 037)
27. Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW & Hodsman AB. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium. Journal of Bone and Mineral Research 2007 22 495-502. (doi:10.1359/jbmr.070104)
28. Balena R, Shih MS & Parfitt AM. Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women. Journal of Bone and Mineral Research 1992 7 1475-1482. (doi:10.1002/jbmr. 5650071216)
29. Epker BN & Frost HM. Periosteal appositional bone growth from age two to age seventy in man. A tetracycline evaluation. Anatomical Record 1966 154 573-577. (doi:10.1002/ar.1091540307)
30. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM & Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. Journal of Clinical Investigation 1999 104 439-446. (doi:10.1172/JCI6610)